
CAS Number16321-99-6
Synonyms2',3',5'-Tri-O-acetyl-2-amino-6-chloropurine Riboside; 2-Amino-6-chloro-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)purine; [(2R,3S,4S,5R)-3,4-diacetyloxy-5-(2-amino-6-chloropurin-9-yl)oxolan-2-yl]methyl acetate
Molecular FormulaC16H18O7N5Cl1
Molecular Weight427.8
Purity96+%
Density1.7g/cm3
Boiling Point637ºC at 760mmHg
Melting Point146.0 to 150.0 °C
AppearanceSolid;Light orange to Yellow to Green powder to crystal
EINECS0
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 16321-99-6 |
| Catalog No. | 2A-0095118 |
| Chinese Name | 2',3',5'-三-O-乙酰-2-氨基-6-氯嘌呤核苷 |
| Synonyms | 2',3',5'-Tri-O-acetyl-2-amino-6-chloropurine Riboside; 2-Amino-6-chloro-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)purine; [(2R,3S,4S,5R)-3,4-diacetyloxy-5-(2-amino-6-chloropurin-9-yl)oxolan-2-yl]methyl acetate |
| Molecular Formula | C16H18O7N5Cl1 |
| Molecular Weight | 427.8 |
| Purity | 96+ |
| Density | 1.7g/cm3 |
| Boiling Point | 637ºC at 760mmHg |
| Melting Point | 146.0 to 150.0 °C |
| Appearance | Solid;Light orange to Yellow to Green powder to crystal |
| Storage Condition | room temperature, dry |
| Application | 2′,3′,5′-Tri-O-acetyl-6-chloroguanosine diacetate is a purine nucleoside analog. Purine nucleoside analogues have broad antitumor activity and target indolent lymphoid malignancies. The anti-cancer me |
| EINECS | 0 |
| HTC | 0 |
| UN(IATA) | 0 |
| PubChem ID | 15827441 |
| MDL Number | MFCD03425473 |
| SMILES | CC(=O)OCC1OC(n2cnc3c(Cl)nc(N)nc32)C(OC(C)=O)C1OC(C)=O |
| InChI | InChI=1S/C16H18ClN5O7/c1-6(23)26-4-9-11(27-7(2)24)12(28-8(3)25)15(29-9)22-5-19-10-13(17)20-16(18)21-14(10)22/h5,9,11-12,15H,4H2,1-3H3,(H2,18,20,21) |
| InChI Key | HLVGVJFVAKPFOZ-SDBHATRESA-N |
| MSDS | msds/95118_1_16321_99_6.pdf |
| Bioactivity | 2′,3′,5′-Tri-O-acetyl-6-chloroguanosine diacetate is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. Related Catalog Research Areas >> Cancer Signaling Pathways >> Cell Cycle/DNA Damage >> Nucleoside Antimetabolite/Analog References [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. Chemical & Physical Properties Density 1.7g/cm3 Boiling Point 637ºC at 760mmHg Melting Point 146.0 to 150.0 °C Molecular Formula C16H18ClN5O7 Molecular Weight 427.80 Flash Point 339ºC Exact Mass 427.08900 PSA 157.75000 LogP 0.96700 Vapour Pressure 4E-16mmHg at 25°C Index of Refraction 1.69 InChIKey HLVGVJFVAKPFOZ-SDBHATRESA-N SMILES CC(=O)OCC1OC(n2cnc3c(Cl)nc(N)nc32)C(OC(C)=O)C1OC(C)=O |
| Use of | 2′,3′,5′-Tri-O-acetyl-6-chloroguanosine diacetate is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. Properties Name (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2-amino-6-chloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate Synonym More Synonyms Biological Activity Description 2′,3′,5′-Tri-O-acetyl-6-chloroguanosine diacetate is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. Related Catalog Research Areas >> Cancer Signaling Pathways >> Cell Cycle/DNA Damage >> Nucleoside Antimetabolite/Analog References [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. Chemical & Physical Properties Exact Mass 427.08900 PSA 157.75000 LogP 0.96700 Index of Refraction 1.69 InChIKey HLVGVJFVAKPFOZ-SDBHATRESA-N |
| Transport Info | Product name: 2',3',5'-Tri-O-acetyl-2-amino-6-chloropurine nucleoside |
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA